Journal
BREAST JOURNAL
Volume 15, Issue 5, Pages 505-509Publisher
WILEY
DOI: 10.1111/j.1524-4741.2009.00767.x
Keywords
biomarkers; breast cancer; mitochondrial DNA; molecular detection
Categories
Funding
- Swiss National Science Foundation [320000-119722/1]
- Swiss Cancer League, Krebsliga Beider Basel and Dr. Hans Altschueler Stiftung
Ask authors/readers for more resources
The recent surge in mitochondrial research has been driven by the identification of mitochondria-associated diseases and the role of mitochondria in apoptosis and aging. Mitochondrial DNA (mtDNA) has been proposed to be involved in carcinogenesis because of its high susceptibility to mutations and limited repair mechanisms in comparison to nuclear DNA. As mtDNA lacks introns, it has been suggested that most mutations will occur in coding sequences. The subsequent accumulation of mutations may lead to tumor formation. By virtue of their clonal nature, high copy number and high frequent mutations may provide a powerful molecular biomarker for the detection of cancer. It has been suggested that the extent of mtDNA mutations might be useful in the prognosis of cancer outcome and/or the response to certain therapies. In this review article, we aim to provide a brief summary of our current understanding of mitochondrial genetics and biology, review the mtDNA alterations reported in breast cancer, and offer some perspectives as to the emergence of mtDNA mutations, including their functional consequences in cancer development, diagnostic criteria, and therapeutic implications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available